Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025)
Xtant Medical Holdings (XTNT) reported Change in Accured Expenses of $958000.0 for Q3 2025, up 333.48% year-over-year from $221000.0 in Q3 2024, and up 4065.22% quarter-over-quarter from $23000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Change in Accured Expenses data on file, last reported at $958000.0 in Q3 2025.
- Change in Accured Expenses for Q3 2025 came in at $958000.0, up 333.48% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.6 million (up 724.76% YoY), and the FY2024 annual result was -$2.9 million, down 176.95% from the prior year.
- Change in Accured Expenses advanced to $958000.0 in Q3 2025 per XTNT's latest filing, from $23000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.7 million in Q1 2025 and troughed at -$1.6 million in Q3 2021.
- A 5-year average of $243526.3 and a median of $221000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2021 and 2024: Change in Accured Expenses surged 10636.36% in 2021, then slumped 788.78% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $270000.0 in 2021, then jumped by 75.93% to $475000.0 in 2022, then surged by 198.74% to $1.4 million in 2023, then tumbled by 175.55% to -$1.1 million in 2024, then jumped by 189.37% to $958000.0 in 2025.
- Business Quant data shows XTNT's Change in Accured Expenses at $958000.0 in Q3 2025, $23000.0 in Q2 2025, and $2.7 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 958,000.00 |
| Sep 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | 221,000.00 |
| Sep 30, 2024 | 221,000.00 |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -675,000.00 |
| Mar 31, 2024 | -675,000.00 |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 660,000.00 |
| Jun 30, 2023 | 660,000.00 |